Normal proinsulin processing despite beta-cell dysfunction in persistent hyperinsulinaemic hypoglycaemia of infancy (nesidioblastosis)

被引:9
|
作者
Leibowitz, G
Weintrob, N
Pikarsky, A
Josefsberg, Z
Landau, H
Glaser, B
Hales, CN
Cerasi, E
机构
[1] HADASSAH UNIV HOSP,DEPT ENDOCRINOL & METAB,MED CTR,IL-91120 JERUSALEM,ISRAEL
[2] SCHNEIDER CHILDRENS MED CTR ISRAEL,INST PEDIAT & ADOLESCENT ENDOCRINOL,PETAH TIQWA,ISRAEL
[3] HEBREW UNIV JERUSALEM,HADASSAH MED CTR,DEPT PEDIAT,JERUSALEM,ISRAEL
[4] ADDENBROOKES HOSP,DEPT CLIN BIOCHEM,CAMBRIDGE,ENGLAND
关键词
nesidioblastosis hypoglycaemia; infancy; proinsulin; pancreatectomy;
D O I
10.1007/s001250050580
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Persistent hyperinsulinaemic hypoglycaemia of infancy (PHHI) is a genetic disorder which causes severe hypoglycaemia in the neonate, The beta cells fail to respond to changes in blood glucose levels in all the stages of the disease, which often ends with NIDDM. Fasting insulin, intact proinsulin and des 31,32 split proinsulin levels were measured in PHHI patients with active disease, patients after partial pancreatectomy, and those in clinical remission. All but one of the pancreatectomized patients developed diabetes and were hyperglycaemic on evaluation. Fasting insulin was comparable in pancreatectomized and medically treated patients. Des 31,32 split proinsulin levels were much higher in pancreatectomized compared to non-pancreatectomized patients (10.7 +/- 2.5 vs 3.4, +/- 0.8 pmol/l, p = 0.001) and age-matched control subjects (3.8 +/- 1.4 pmol/l, p = 0.018). Also the ratio of des 31,32 split proinsulin to total insulin plus proinsulin-like peptides was higher in pancreatectomized patients (18.7 +/- 2.8 vs 7.2 +/- 0.8 % in non-pancreatectomized patients, p = 0.001, and 6.8 +/- 2.1 % in normal control subjects, p = 0.004). Furthermore, des 31,32 split: proinsulin was the dominating species of proinsulin-like molecules in the pancreatectomized patients (62.7 +/- 1.6 % vs 45.5 +/- 3.8 %, and 49.0 +/- 3.2 % in non-pancreatectomized patients and control subjects, respectively, p = 0.001 and p = 0.0002), Intact proinsulin levels, and the proinsulin percentage, tended to be higher in pancreatectomized patients, however, the differences did not reach statistical significance. All parameters were similar in non-pancreatectomized patients and age-matched control subjects. Subgroup analysis showed comparable proinsulin-like peptide levels in patients with active disease and those in apparent clinical remission. Fasting levels of insulin and proinsulin-like peptides were also measured in a larger group of healthy children and young adults. Insulin and des 31,32 split: proinsulin increased with age, the differences being most prominent when the young age group (0-8 years) was compared to the older groups (8-16 and > 16 years). The fasting levels of plasma insulin were correlated with those of intact proinsulin and des 31,32 split proinsulin (r = 0.82 and 0.81, respectively). Fasting insulin, intact proinsulin and des 31,32 split proinsulin were correlated with BMI (r = 0.55, 0.56 and 0.53, respectively). In summary, relative hyperproinsulinaemia was noted only in PHHI patients with increased secretory demand following pancreatectomy, but not in patients with active disease or those in spontaneous clinical remission. These findings suggest that abnormal proinsulin processing is not an intrinsic feature of PHHI despite the severe beta-cell dysfunction.
引用
收藏
页码:1338 / 1344
页数:7
相关论文
共 30 条
  • [21] Endoplasmic reticulum Ca2+ is important for the proteolytic processing and intracellular transport of proinsulin in the pancreatic beta-cell
    Guest, PC
    Bailyes, EM
    Hutton, JC
    BIOCHEMICAL JOURNAL, 1997, 323 : 445 - 450
  • [22] Reduced Beta-Cell Secretory Capacity in Pancreatic Insufficient Cystic Fibrosis despite Normal Glucose Tolerance
    Sheikh, Saba
    Gudipaty, Lalitha
    De Leon, Diva D.
    Hadjiliadis, Denis
    Kubrak, Christina
    Peleckis, Amy
    Rosenfeld, Nora
    Nyirjesy, Sarah
    Malik, Saloni
    Cuchel, Marina
    Stefanovski, Darko
    Rubenstein, Ronald C.
    Kelly, Andrea
    Rickels, Michael R.
    DIABETES, 2016, 65 : A459 - A459
  • [23] SOMATOSTATIN REGULATION OF BETA-CELL FUNCTION IN THE NORMAL HUMAN FETUSES AND IN NEONATES WITH PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA
    OTONKOSKI, T
    ANDERSSON, S
    SIMELL, O
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (01): : 184 - 188
  • [24] beta-cell lines derived from transgenic Cpe(fat)/Cpe(fat) mice are defective in carboxypeptidase E and proinsulin processing
    Varlamov, O
    Fricker, LD
    Furukawa, H
    Steiner, DF
    Langley, SH
    Leiter, EH
    ENDOCRINOLOGY, 1997, 138 (11) : 4883 - 4892
  • [25] Intermittent Hypoxia-induced Pancreatic Beta Cell Dysfunction involves Mitochondrial ROS impaired Proinsulin processing
    Wang, Ning
    Khan, Shakil A.
    Nanduri, Prabhakar R.
    Nanduri, Jayasri
    FASEB JOURNAL, 2013, 27
  • [26] WHAT BETA-CELL DEFECT COULD LEAD TO HYPERPROINSULINEMIA IN NIDDM - SOME CLUES FROM RECENT ADVANCES MADE IN UNDERSTANDING THE PROINSULIN-PROCESSING MECHANISM
    RHODES, CJ
    ALARCON, C
    DIABETES, 1994, 43 (04) : 511 - 517
  • [27] Persistence of normal beta-cell numbers up to diabetes onset supports a primary role of defective proinsulin maturation in dominant negative insulin deficiency in Akita mice
    Wang, Jie
    Cao, Yun
    Voogd, Keith
    Chen, Ying
    Osei, Kwame
    Steiner, Donald F.
    DIABETES, 2008, 57 : A459 - A459
  • [28] Early phase insulin secretion is increased in subjects with normal fasting glucose and metabolic syndrome: a premature feature of beta-cell dysfunction
    Spadaro, L.
    Alagona, C.
    Palermo, F.
    Piro, S.
    Calanna, S.
    Parrinello, G.
    Purrello, F.
    Rabuazzo, A. M.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2011, 21 (03) : 206 - 212
  • [29] Adenovirus-mediated gene transfer into isolated mouse adult pancreatic islets: Normal beta-cell function despite induction of an anti-adenovirus immune response
    Sigalla, J
    David, A
    Anegon, I
    Fiche, M
    Huvelin, JM
    Boeffard, F
    Cassard, A
    Soulillou, JP
    LeMauff, B
    HUMAN GENE THERAPY, 1997, 8 (13) : 1625 - 1634
  • [30] PANCREATIC BETA-CELL DYSFUNCTION AS THE PRIMARY GENETIC LESION IN NIDDM - EVIDENCE FROM STUDIES IN NORMAL GLUCOSE-TOLERANT INDIVIDUALS WITH A FIRST-DEGREE NIDDM RELATIVE
    PIMENTA, W
    KORYTKOWSKI, M
    MITRAKOU, A
    JENSSEN, T
    YKIJARVINEN, H
    EVRON, W
    DAILEY, G
    GERICH, J
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (23): : 1855 - 1861